Answer
The safety of ipratropium bromide monohydrate during human pregnancy is unestablished, so use requires maternal benefits to outweigh potential fetal risks; nonclinical studies found no embryotoxic or teratogenic effects after inhaled or intranasal doses considerably above human recommendations.
Sources for this answer
- Atrovent Inhaler CFC-FreeBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked